Page 44 - ம்ட் ஆண்டர்சன் புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting ACCESSWIRE 20 May 2021, 22:43 GMT+10 SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) today announced the highlights of the abstract regarding patient outcomes associated with cancer-related diarrhea ( CRD ) by Napo Pharmaceuticals, Inc. ( Napo ), Jaguar s wholly owned subsidiary, and Napo s collaborators that has been accepted for poster presentation at the American Society of Clinical Oncology (ASCO ®) Annual Meeting, which will be held virtually from June 4-8, 2021. In addition, two CRD-related abstracts from Napo and its collaborators have been accepted for online publication at ASCO.

United statesUniversity of texasLee schwartzbergEric roelandPabloc okhuysenPeter hodgeDivision of internal medicineSociety scientific program committeeAmerican society of clinical oncologyJaguar health incCancer centerMd anderson cancer centerHarvard medical schoolDepartment of infectious diseasesExchange commissionEmployee health